For which solid tumors do you find NGS genomic profiling to be most valuable for identifying molecular drivers that can reliably guide the use of targeted therapy?

For which solid tumors do you find NGS genomic profiling to be most valuable for identifying molecular drivers that can reliably guide the use of targeted therapy?

For which solid tumors do you find NGS genomic profiling to be most valuable for identifying molecular drivers that can reliably guide the use of targeted therapy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Suzhan Zhang, MD

Professor Suzhan Zhang, MD

Director, Cancer Institute
Zhejiang University Multidisciplinary Diagnosis and Treatment Center for Colorectal Cancer
Zhejiang University School of Medicine
Hangzhou, China